RSPR-007 Mannitol Challenge Trial

Summary

This is a double-blind, randomised, placebo-controlled, cross-over, Phase 2 trial evaluating two doses (a low and a high) of CRD007 for the treatment of asthmatic trial subjects with a positive asthma test (mannitol challenge) prior to enrolment.

Timeline

Start

2015-03

Primary completion

2015-07

Completion

2015-07

Drugs

Indications